Gene expression and regulation in hematological malignancies and breast cancer, Tumor Immunology, and the interplay between cancer cells and their Tumor Microenvironment

Miller KD, Steding CE, Prasad N, Rojas LA, Herbert B-S. Inhibiting telomerase to reverse trastuzumab (T) resistance in HER2+ breast cancer. San Antonio Breast Cancer Symposium. December, 2012. Sprouse AA, Steding CE, Sloan R, Herbert B-S. Pharmaceutical Regulation of Telomerase. J Cell Mol Med. 2012; 16, 1-7. Steding CE, Wu S, Zhang YP, Jeng MH, Elzey BD, Kao C. The Role of Interleukin-12 on Modulating Myeloid-Derived Suppressor Cells, Increasing Overall Survival, and Reducing Metastasis. Immunology. 2011; 133, 221-238. Koziel JE, Fox MJ, Steding CE, Sprouse AA, Herbert B-S. Medical genetics and epigenetics of telomerase. J Cell Mol Med. 2011; 15 (3): 457-467. Steding C, Wu S, Zhang Y, Elzey B, Jeng MH, Kao C. The Effects of IL-12 on MDSC Activity. Tumor Immune Suppression Meeting. July, 2010. Mellon MJ, Bae KH, Steding CE, Jimenez JA, Kao C, Gardner TA. Suppression of Renal Cell Carcinoma Growth and Metastasis with Sustained Antiangiogenic Gene Therapy. Hum Gene Ther. 2008; 19:487-495. Xiong L, Steding C, Jimenez JA, Gardner TA, Kao C. Development of prostate-restricted replication competent adenoviral vectors. In Cancer and Gene Therapy. Transworld Research Network. Kerala, India. 2007.